PPA was highest in samples with a tumor fraction of >10%, especially for potentially actionable alterations in PIK3CA (93%) and BRCA1/2 (95%) (Supplementary Fig. 7a–c, Supplementary Data 9). This evidence concerns the gene BRCA1 and neoplasm.